ZKY001
/ Zhaoke Ophthalmology
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
September 24, 2024
ZKY001 With Different Concentrations in the Treatment of Corneal Epithelial Defect After Primary Pterygium Excision: A Multicenter, Randomized, Double-Masked Phase 2 Study
(AAO 2024)
- "And the treatment-emergent adverse event rate was low (9.0%), with no significant difference . Conclusion ZKY001 can effectively improve CED and relieve foreign body sensation and pain after primary pterygium surgery, providing a new treatment for promoting corneal repairment and relieving discomfort."
Clinical • P2 data • Ophthalmology
January 19, 2024
ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial
(clinicaltrials.gov)
- P2 | N=180 | Completed | Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
New P2 trial
January 17, 2024
TPRK: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops
(clinicaltrials.gov)
- P2 | N=120 | Completed | Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
New P2 trial
September 17, 2021
Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects
(clinicaltrials.gov)
- P2; N=105; Recruiting; Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.; Trial primary completion date: Jan 2021 ➔ Dec 2021
Clinical • Trial primary completion date • Transplantation
January 06, 2021
Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects
(clinicaltrials.gov)
- P2; N=105; Recruiting; Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.; Not yet recruiting ➔ Recruiting; Trial completion date: Dec 2020 ➔ Dec 2021; Trial primary completion date: Oct 2020 ➔ Jan 2021
Clinical • Enrollment open • Trial completion date • Trial primary completion date • Transplantation
May 27, 2020
Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects
(clinicaltrials.gov)
- P2; N=105; Not yet recruiting; Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.; Initiation date: Apr 2020 ➔ Jul 2020
Clinical • Trial initiation date • Ophthalmology • Transplantation
January 14, 2020
Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects
(clinicaltrials.gov)
- P2; N=105; Not yet recruiting; Sponsor: Lee's Pharmaceutical Limited
Clinical • New P2 trial
1 to 7
Of
7
Go to page
1